• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《N-芳基磺酰基嘧啶酮作为抗癌剂的鉴定》的更正

Correction to: Identification of N-arylsulfonylpyrimidones as anticancer agents.

作者信息

Subramanian Santhosh, Boggu Pulla Reddy, Yun Jieun, Jung Sang-Hun

机构信息

College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon, 34134, Republic of Korea.

Department of Pharmaceutical Engineering, Cheongju University, Cheongwon-gu, Cheongju, 28503, Republic of Korea.

出版信息

Arch Pharm Res. 2019 Apr;42(4):371. doi: 10.1007/s12272-019-01121-4.

DOI:10.1007/s12272-019-01121-4
PMID:30725248
Abstract

The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as: The authors declare no conflict of interest.

摘要

作者希望纳入在线发表文章的利益冲突声明。正确的利益冲突声明应表述为：作者声明无利益冲突。

相似文献

1
Correction to: Identification of N-arylsulfonylpyrimidones as anticancer agents.对《N-芳基磺酰基嘧啶酮作为抗癌剂的鉴定》的更正
Arch Pharm Res. 2019 Apr;42(4):371. doi: 10.1007/s12272-019-01121-4.
2
Correction to: Anti-inflammatory activity of caffeic acid derivatives isolated from the roots of Salvia miltiorrhiza Bunge.对《从丹参根部分离的咖啡酸衍生物的抗炎活性》的更正
Arch Pharm Res. 2019 Apr;42(4):378. doi: 10.1007/s12272-018-1090-7.
3
Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase.对《来自独活的抑制晚期糖基化终产物形成及人重组醛糖还原酶的二氢黄颜木素型香豆素》的修正
Arch Pharm Res. 2019 Apr;42(4):379. doi: 10.1007/s12272-019-01113-4.
4
Correction to: Lifespan-extending property of 6-shogaol from Zingiber officinale Roscoe in Caenorhabditis elegans.对《姜科植物姜中6-姜辣素对线虫的寿命延长特性》一文的修正
Arch Pharm Res. 2019 Apr;42(4):370. doi: 10.1007/s12272-019-01119-y.
5
Correction to: Anti-inflammatory activity of compounds from the rhizome of Cnidium officinale.《关于“蛇床子根茎化合物的抗炎活性”的更正》
Arch Pharm Res. 2019 Apr;42(4):381. doi: 10.1007/s12272-018-1096-1.
6
Correction to: Varilactones and wortmannilactones produced by Penicillium variabile cultured with histone deacetylase inhibitor.对以下内容的修正：用组蛋白去乙酰化酶抑制剂培养可变青霉产生的变内酯和渥曼青霉素内酯 。
Arch Pharm Res. 2019 Apr;42(4):377. doi: 10.1007/s12272-018-1095-2.
7
Correction to: Saroclazines A-C, thio-diketopiperazines from mangrove-derived fungi Sarocladium kiliense HDN11-84.
Arch Pharm Res. 2019 Apr;42(4):376. doi: 10.1007/s12272-019-01112-5.
8
Correction to: Polygonumnolides A1-B3, minor dianthrone derivatives from the roots of Polygonum multiflorum Thunb.
Arch Pharm Res. 2019 Apr;42(4):375. doi: 10.1007/s12272-018-1092-5.
9
Identification of N-arylsulfonylpyrimidones as anticancer agents.鉴定 N-芳基磺酰基嘧啶酮类化合物为抗癌剂。
Arch Pharm Res. 2018 Mar;41(3):251-258. doi: 10.1007/s12272-018-1003-9. Epub 2018 Jan 13.
10
Correction to: Development of a simultaneous LC-MS/MS method to predict in vivo drug-drug interaction in mice.
Arch Pharm Res. 2019 Apr;42(4):380. doi: 10.1007/s12272-018-1085-4.